Breaking Down Fuji Seal International, Inc. Financial Health: Key Insights for Investors

Curious whether Fuji Seal International (7864.T) is a value play or a growth story? Look closer: in FY ending March 31, 2025 the company posted net sales of ¥212.345 billion (TTM ¥216.44 billion as of Sept 30, 2025) with a five‑year revenue growth trend climbing from 4.09% in 2022 to 8.00% in 2025, revenue per employee of ¥38.38 million across 5,639 staff, and a low valuation at a P/S of 0.71 versus a market cap near ¥154.39 billion (share price ¥2,900 on Nov 19, 2025); profitability is improving-operating income jumped 41.6% to ¥18.844 billion with an 8.9% operating margin and net income of ¥12.199 billion (EPS ¥224.93)-while the balance sheet shows total assets of ¥209.822 billion, shareholders' equity ¥145.269 billion, a conservative debt‑to‑equity of 5.29% and net cash of ¥25.05 billion (cash & marketable securities ¥32.65 billion vs total debt ¥7.60 billion); liquidity is solid (current ratio 2.37, quick ratio 1.88), operating cash flow rose to ¥21.34 billion and free cash flow to ¥14.69 billion, and valuation metrics (P/E 10.55, forward P/E 9.80, EV/EBITDA 4.53, EV/FCF 8.34) sit against an average analyst target of ¥3,809.45 implying about 41.88% upside-all set against tangible risks from raw material and currency volatility, regulatory shifts, supply‑chain disruption and competitive tech advances that investors should weigh before diving deeper

Fuji Seal International, Inc. (7864.T) - Revenue Analysis

• Fiscal year 2025 net sales: ¥212.345 billion
• TTM revenue (as of Sep 30, 2025): ¥216.44 billion (YoY +4.56%)
• Workforce: 5,639 employees
• Revenue per employee: ≈ ¥38.38 million
• Market capitalization: ¥154.39 billion (share price ¥2,900 as of Nov 19, 2025)
• Price-to-sales (P/S) ratio: 0.71

• Five-year revenue trend: consistent annual increases with an accelerating pattern through FY2024, moderating in TTM to mid-single-digit YoY growth.
• Valuation note: P/S of 0.71 indicates the market values the company below one times annual sales, implying modest revenue-based valuation relative to peers.

Fuji Seal International, Inc. (7864.T) - Profitability Metrics

• Fiscal year end: March 31, 2025 (comparisons vs FY2024)
• Strong year-over-year growth across operating income, ordinary profit, and net income
• Margin expansion reflects both revenue mix improvement and tighter cost control

• Operating income jumped to ¥18.844 billion in FY2025, a 41.6% increase that drove margin expansion to 8.9%.
• Ordinary profit rose to ¥18.323 billion (+24.4%), signaling improved core profitability before extraordinary items.
• Net income attributable to owners increased to ¥12.199 billion (+18.7%), supporting a higher EPS of ¥224.93.
• Net profit margin of 5.74% in FY2025 indicates effective cost management and better conversion of revenue to bottom-line earnings.

Fuji Seal International, Inc. (7864.T) - Debt vs. Equity Structure

Fuji Seal International's balance sheet as of March 31, 2025 demonstrates a conservative capital structure with a dominant equity base and a net cash position that supports financial flexibility and resilience.

• Total assets: ¥209.822 billion
• Shareholders' equity: ¥145.269 billion
• Equity ratio: ≈69.3%
• Debt-to-equity ratio: 5.29%
• Cash and marketable securities: ¥32.65 billion
• Total debt: ¥7.60 billion
• Net cash position: ¥25.05 billion (Cash & marketable securities minus total debt)
• Interest coverage ratio: 71.81
• Net debt to EBITDA: -0.72 (net cash relative to EBITDA)

The figures above indicate low leverage and a strong ability to cover interest expense and withstand earnings volatility. Key ratios and balances can be summarized as follows:

Investors evaluating capital structure should weigh the benefits of a strong equity ratio and net cash - including financial flexibility for investment, acquisitions, or dividends - against any potential opportunity cost of holding larger cash balances. For broader context on the company's strategy and ownership that interacts with capital allocation decisions, see Fuji Seal International, Inc.: History, Ownership, Mission, How It Works & Makes Money

Fuji Seal International, Inc. (7864.T) - Liquidity and Solvency

• Current ratio: 2.37 - comfortable coverage of short-term liabilities.
• Quick ratio: 1.88 - strong immediate liquidity excluding inventories.
• Operating cash flow (FY 2025): ¥21.34 billion, up from ¥19.93 billion in FY 2024.
• Free cash flow (FY 2025): ¥14.69 billion, up from ¥13.63 billion in FY 2024.
• Cash & cash equivalents (end FY 2025): ¥29.051 billion, up from ¥22.788 billion in FY 2024.
• Net increase in cash & equivalents (FY 2025): ¥6.263 billion, versus ¥5.440 billion in FY 2024.

• Consistent positive operating and free cash flow trends support reinvestment and balance-sheet flexibility.
• Elevated cash reserves (¥29.051 billion) provide a buffer for cyclical pressures and funding for M&A or capex.
• The liquidity ratios indicate minimal short-term solvency risk absent a significant adverse shock.

Fuji Seal International, Inc. (7864.T) - Valuation Analysis

• Trailing P/E: 10.55 - implies a moderate valuation relative to last twelve months' earnings.
• Forward P/E: 9.80 - indicates analysts expect earnings improvement, lowering the price paid per expected yen of earnings.
• EV/EBITDA: 4.53 - a low multiple suggesting the enterprise value is modest relative to operating profitability before non-cash charges and financing costs.
• EV/Free Cash Flow: 8.34 - shows the market values the company at a little over eight times its free cash flow, a reasonably conservative level.
• EV/Operating Cash Flow: 5.74 - reflects a valuation that is supportive relative to operational cash generation.
• Analyst average price target: ¥3,809.45 - implies a 41.88% upside from the current price of ¥2,685.

• Investor considerations: low EV/EBITDA and EV/OCF suggest the business generates cash efficiently relative to its enterprise value; the forward P/E below 10 flags analysts expect earnings improvement; the sizeable analyst target premium signals market analysts see room for re-rating.
• Risks to monitor: earnings consistency, capital expenditure needs affecting free cash flow, and macro/FX influences on Japanese export-oriented packaging demand.

Fuji Seal International, Inc. (7864.T) - Risk Factors

• Fluctuations in raw material prices

• Currency exchange rate volatility

• Economic downturns in key markets

• Regulatory changes in the packaging industry

• Supply chain disruptions

• Technological advancements by competitors

Fuji Seal International, Inc. (7864.T) - Growth Opportunities

• Emerging-market expansion: increased factory footprint and sales channels across Southeast Asia, India, Latin America and Africa can capture rising demand for packaged foods and pharmaceuticals. Targeting a 5-10% CAGR in these regions could add ¥10-25 billion in incremental annual sales over 3-5 years.
• Innovative packaging solutions: development of high-barrier, convenience, and smart packaging (QR/anti-counterfeit features) can command premium pricing and higher margin contracts with multinational food and pharma customers.
• Strategic M&A and partnerships: bolt-on acquisitions in niche labeling, cold-chain solutions, or regional converters could accelerate distribution and cross-sell opportunities, lowering customer acquisition costs.
• Sustainability-driven product suite: scalable compostable films, mono-material laminates and reduced-CO2 processes meet global procurement mandates and can enable preferential sourcing by large retailers.
• Digital transformation: investment in Industry 4.0 (automation, MES) and e-commerce enablement for smaller customers improves throughput, reduces variable costs, and shortens order-to-cash cycles.
• Data and analytics: leveraging production and customer data to optimize SKUs, reduce waste and enable targeted B2B marketing increases gross margin and customer retention.

• CapEx allocation: prioritized investments in high-growth plants and automation to raise capacity utilization from current mid-70s% toward 85-90%-driving operating leverage.
• New product R&D: increasing R&D intensity toward ~1.5-2.0% of sales to accelerate time-to-market for sustainable and smart-packaging lines.
• Supply-chain resiliency: regionalizing raw-material sourcing to reduce FX and freight volatility, improving gross margin stability.

• Set up regional innovation centers in APAC and LATAM to co-develop solutions with local F&B and pharma customers, shortening adoption cycles.
• Pursue selective tuck-in acquisitions focused on biodegradable films and regional converters to expand product breadth and distribution.
• Implement advanced analytics across pricing, procurement and production to reduce waste 3-5% and improve gross margin by 100-200 bps.
• Launch pilot programs for subscription/consumables models with key OEMs to stabilize recurring revenue streams.